Go to deals
Food & Beverage | Private Equity

Unis Fish Food has been acquired by Les Toques Blanches du Monde

GSH Services S.R.O. has sold its French non-core subsidiary Unis Fish Food to Les Toques Blanches du Monde.

Based in Villefranche-sur-Saoône, France, and founded in 1989, Unis Fish Food is a premium smoked salmon producer dedicated to mass retailers and HORECA.

Founded in 2011 and based in Lyon, France, Les Toques Blanches du Monde is a French brand of premium food products that has the ambition to become a key player in the premium food sector. By selecting authentic products with a unique taste and incredible history, the company is committed to preserving the world’s culinary heritage. Its distribution network, both in France and internationally, is retail, duty free and department stores.

Oaklins’ team in France advised the Slovakian group GS Holding on the disposal of its non-core French subsidiary Unis Fish Food.

Parties

Talk to the deal team

Philippe Hermant

Senior Advisor
Paris, France
Oaklins France

Related deals

ELSA Group has sold SoFine Foods to The New Originals Company
Food & Beverage

ELSA Group has sold SoFine Foods to The New Originals Company

The New Originals Company has acquired SoFine Foods from the ELSA Group.

Learn more
Den Berk Délice accelerates growth through strategic partnership
Private Equity | Agriculture

Den Berk Délice accelerates growth through strategic partnership

Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.

Learn more
Xiel Limited has been acquired by MIS Healthcare
Private Equity | Healthcare

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Learn more